Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. [electronic resource]
Producer: 20180502Description: 1216-1223 p. digitalISSN:- 1499-2752
- AMP Deaminase -- genetics
- ATP Binding Cassette Transporter, Subfamily G, Member 2 -- genetics
- Antirheumatic Agents -- therapeutic use
- Arthritis, Juvenile -- diagnostic imaging
- Child
- Child, Preschool
- Female
- Ferredoxin-NADP Reductase -- genetics
- Genotype
- Humans
- Infant
- Male
- Methotrexate -- therapeutic use
- Methylenetetrahydrofolate Dehydrogenase (NADP) -- genetics
- Methylenetetrahydrofolate Reductase (NADPH2) -- genetics
- Minor Histocompatibility Antigens -- genetics
- Multidrug Resistance-Associated Protein 2
- Neoplasm Proteins -- genetics
- Pharmacogenetics
- Polymorphism, Single Nucleotide
- Severity of Illness Index
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.